ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,431Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 1171

$1.23M Total Retail Price of All Prescriptions

Rank: 27 out of 1171

549 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 549 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 549 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 18,088 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
FUROSEMIDE 924 762 1 6
OMEPRAZOLE 821 598 2 5
HYDROCODONE-ACETAMINOPHEN 741 516 S3 3 8
SIMVASTATIN 675 519 4 1
METFORMIN HCL 621 477 5 7
LEVOTHYROXINE SODIUM 612 536 6 4
LISINOPRIL 595 431 7 3
AMLODIPINE BESYLATE 520 404 8 2
METOPROLOL TARTRATE 455 375 9 11
GABAPENTIN 372 283 10 16
WARFARIN SODIUM 369 250 11 12
ATORVASTATIN CALCIUM 327 226 12 10
CARVEDILOL 322 255 13 20
DONEPEZIL HCL 317 317 14 24
HYDROCHLOROTHIAZIDE 294 192 15 9
GLIMEPIRIDE 288 184 16 34
CITALOPRAM HBR 273 183 17 22
POTASSIUM CHLORIDE 273 201 17 19
ZOLPIDEM TARTRATE 272 177 19 21
ATENOLOL 236 181 20 15
ISOSORBIDE MONONITRATE ER 233 215 21 44
NEXIUM 229 179 22 25
DIGOXIN 229 206 22 68
AZITHROMYCIN 227 160 24 43
MIRTAZAPINE 215 170 25 50
NAMENDA 202 202 26 42
FAMOTIDINE 199 188 27 75
ALLOPURINOL 188 144 28 31
CLOPIDOGREL 182 151 29 35
NOVOLIN R 174 161 30 155
PAROXETINE HCL 174 147 30 62
RANITIDINE HCL 172 130 32 38
METOPROLOL SUCCINATE 167 142 33 17
IBUPROFEN 166 136 34 80
TRAMADOL HCL 163 112 35 18
CYMBALTA 157 100 36 64
SERTRALINE HCL 155 132 37 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 154 128 38 26
ROPINIROLE HCL 148 107 39 119
ENALAPRIL MALEATE 141 90 40 73
PLAVIX 138 120 41 55
PANTOPRAZOLE SODIUM 137 93 42 29
ADVAIR DISKUS 134 108 43 51
LOSARTAN POTASSIUM 132 116 44 14
CIPROFLOXACIN HCL 127 102 45 61
RISPERIDONE 126 110 46 77
LEVOFLOXACIN 126 96 46 105
DIOVAN 124 109 48 32
FLUTICASONE PROPIONATE 124 91 48 30
CLONIDINE HCL 124 110 48 45
PHENYTOIN SODIUM EXTENDED 121 78 51 137
PROAIR HFA 119 93 52 49
KLOR-CON M20 119 85 52 41
LANTUS 118 87 54 46
TAMSULOSIN HCL 116 105 55 28
ZETIA 114 80 56 63
CELEBREX 113 77 57 100
MECLIZINE HCL 110 79 58 115
PRAVASTATIN SODIUM 105 100 59 13
LACTULOSE 105 87 59 108
ALENDRONATE SODIUM 103 96 61 33
SPIRIVA 102 90 62 57
CYCLOBENZAPRINE HCL 100 57 R 63 67
CRESTOR 98 76 64 27
JANUVIA 96 96 65 66
AMITRIPTYLINE HCL 96 51 R 65 74
LYRICA 96 43 65 127
MELOXICAM 95 79 68 56
LOSARTAN-HYDROCHLOROTHIAZIDE 92 91 69 40
INSULIN SYRINGE 86 42 70 71
VYTORIN 86 75 70 191
SULFAMETHOXAZOLE-TRIMETHOPRIM 83 62 72 109
ACTOS 82 46 73 123
COMBIVENT 79 62 74 152
NAPROXEN 78 38 75 95
FENTANYL 77 58 S2 76 89
LOVAZA 75 47 77 118
LANTUS SOLOSTAR 75 58 77 90
NITROSTAT 73 61 79 180
MORPHINE SULFATE ER 72 38 S2 80 146
DILTIAZEM 24HR CD 72 71 80 101
ENALAPRIL-HYDROCHLOROTHIAZIDE 70 61 82 359
TRICOR 69 59 83 140
NOVOLOG MIX 70-30 69 26 83 207
GLIPIZIDE 67 65 85 47
ONGLYZA 67 47 85 214
SINGULAIR 66 52 87 78
EVISTA 65 52 88 154
BISOPROLOL-HYDROCHLOROTHIAZIDE 63 51 89 166
DIOVAN HCT 63 50 89 65
PROMETHAZINE HCL 63 43 R 89 87
CLOZAPINE 63 63 89 308
ATENOLOL-CHLORTHALIDONE 63 46 89 241
CILOSTAZOL 62 52 94 271
BUSPIRONE HCL 62 37 94 129
AMOXICILLIN 62 37 94 111
CARBIDOPA-LEVODOPA 61 60 97 107
GLYBURIDE 61 61 R 97 97
SPIRONOLACTONE 59 51 99 53
OXYBUTYNIN CHLORIDE ER 57 57 100 135
ESCITALOPRAM OXALATE 57 38 100 69
RAMIPRIL 57 57 100 85
POLYETHYLENE GLYCOL 3350 57 52 100 72
IPRATROPIUM-ALBUTEROL 56 55 104 130
DILTIAZEM 24HR ER 56 51 104 112
LEVEMIR 55 55 106 167
PREDNISONE 55 41 106 39
METFORMIN HCL ER 54 31 108 52
CEFDINIR 53 43 109 197
FLUOXETINE HCL 51 41 110 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 9, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.